{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:27:37Z","timestamp":1791304057611,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Biotechnology, Govt of India","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12253-019-00768-0","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T17:02:44Z","timestamp":1574701364000},"page":"2091-2103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade"],"prefix":"10.1007","volume":"26","author":[{"given":"Sefinew","family":"Molla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krushna Chandra","family":"Hembram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhajit","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmayee","family":"Sethy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajalaxmi","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanakya Nath","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"768_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.oraloncology.2016.10.008","volume":"62","author":"PP Naik","year":"2016","unstructured":"Naik PP, Das DN, Panda PK, Mukhopadhyay S, Sinha N, Praharaj PP, Agarwal R, Bhutia SK (2016) Implications of cancer stem cells in developing therapeutic resistance in oral cancer. Oral Oncol 62:122\u2013135","journal-title":"Oral Oncol"},{"issue":"11","key":"768_CR2","first-page":"30","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(11):30","journal-title":"CA Cancer J Clin"},{"key":"768_CR3","doi-asserted-by":"publisher","first-page":"12670","DOI":"10.1038\/srep12670","volume":"5","author":"R Dufour","year":"2015","unstructured":"Dufour R, Daumar P, Mounetou E (2015) BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib. Sci Rep 5:12670","journal-title":"Sci Rep"},{"key":"768_CR4","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-05-1761","volume":"12","author":"A Gelbard","year":"2006","unstructured":"Gelbard A, Garnett CT, Abrams SI, Patel V, Gutkind JS, Palena C, Tsang KY, Schlom J, Hodge JW (2006) Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Clin Cancer Res 12:1897\u20131905","journal-title":"Clin Cancer Res"},{"key":"768_CR5","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1128\/AAC.50.5.1859-1860.2006","volume":"50","author":"DN Nandakumar","year":"2006","unstructured":"Nandakumar DN, Nagaraj VA, Vathsala PG, Rangarajan P, Padmanaban G (2006) Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents Chemother 50:1859\u20131860","journal-title":"Antimicrob Agents Chemother"},{"key":"768_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1440-1681.2011.05648.x","volume":"39","author":"SC Gupta","year":"2012","unstructured":"Gupta SC, Patchva S, Koh W, Aggarwal BB (2012) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39:283\u2013299","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"12","key":"768_CR7","first-page":"651","volume":"24","author":"RR Satoskar","year":"1986","unstructured":"Satoskar RR, Shah SJ, Shenoy SG (1986) Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol 24(12):651\u2013654","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"768_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ijc.10183","volume":"9","author":"ZM Shao","year":"2002","unstructured":"Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M (2002) Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 9:234\u2013240","journal-title":"Int J Cancer"},{"issue":"13","key":"768_CR9","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1016\/j.febslet.2005.04.013","volume":"579","author":"CH Park","year":"2005","unstructured":"Park CH, Hahm ER, Park S, Kim HK, Yang CH (2005) The inhibitory mechanism of curcumin and its derivative against beta-catenin\/Tcf signaling. FEBS Lett 579(13):2965\u20132971","journal-title":"FEBS Lett"},{"key":"768_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","volume":"269","author":"AB Kunnumakkara","year":"2008","unstructured":"Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199\u2013225","journal-title":"Cancer Lett"},{"key":"768_CR11","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3892\/or.2016.5002","volume":"36","author":"HS Shang","year":"2016","unstructured":"Shang HS, Chang CH, Chou YR, Yeh MY, Au MK, Lu HF, Chu YL, Chou HM, Chou HC, Shih YL, Chung JG (2016) Curcumin causes DNA damage and affects associated protein expression in HeLa human cervical cancer cells. Oncol Rep 36:2207\u20132215","journal-title":"Oncol Rep"},{"key":"768_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2004.09.041","volume":"223","author":"A Duvoix","year":"2005","unstructured":"Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M (2005) Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223:181\u2013190","journal-title":"Cancer Lett"},{"key":"768_CR13","first-page":"3867","volume":"35","author":"CY Ting","year":"2015","unstructured":"Ting CY, Wang HE, Yu CC, Liu HC, Liu YC, Chiang IT (2015) Curcumin triggers DNA damage and inhibits expression of DNA repair proteins in human lung cancer cells. Anticancer Res 35:3867\u20133873","journal-title":"Anticancer Res"},{"key":"768_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.biopha.2017.09.078","volume":"97","author":"Q Zhao","year":"2018","unstructured":"Zhao Q, Guan J, Qin Y, Ren P, Zhang Z, Lv J, Sun S, Zhang C, Mao W (2018) Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination. Biomed Pharmacother 97:115\u2013119","journal-title":"Biomed Pharmacother"},{"key":"768_CR15","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/carcin\/bgt240","volume":"34","author":"H Ogiwara","year":"2013","unstructured":"Ogiwara H, Ui A, Shiotani B, Zou L, Yasui A, Kohno T (2013) Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to a PARP inhibitor. Carcinogenesis 34:2486\u20132497","journal-title":"Carcinogenesis"},{"key":"768_CR16","first-page":"256","volume":"13","author":"A Kumar","year":"2013","unstructured":"Kumar A, Bora U (2013) Interactions of curcumin and its derivatives with nucleic acids and their implications. Mini-Rev Med Chem 13:256\u2013264","journal-title":"Mini-Rev Med Chem"},{"key":"768_CR17","doi-asserted-by":"publisher","first-page":"30072","DOI":"10.18632\/oncotarget.5019","volume":"6","author":"E Caiola","year":"2015","unstructured":"Caiola E, Salles D, Frapolli R, Lupi M, Rotella G, Ronchi A, Garassino MC, Mattschas N, Colavecchio S, Broggini M, Wiesm\u00fcller L (2015) Base excision repair-mediated resistance to cisplatin in KRAS (G12C) mutant NSCLC cells. Oncotarget 6:30072","journal-title":"Oncotarget"},{"key":"768_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/annonc\/mdq322","volume":"22","author":"C Underhill","year":"2011","unstructured":"Underhill C, Toulmonde M, Bonnefoi H (2011) A review of PARP inhibitors: from bench to bedside. Ann Oncol 22:268\u2013279","journal-title":"Ann Oncol"},{"key":"768_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0027-5107(00)00039-7","volume":"451","author":"A Memisoglu","year":"2000","unstructured":"Memisoglu A, Samson L (2000) Base excision repair in yeast and mammals. Mutat Res 451:39\u201351","journal-title":"Mutat Res"},{"key":"768_CR20","doi-asserted-by":"publisher","first-page":"23028","DOI":"10.1074\/jbc.M202390200","volume":"277","author":"V Schreiber","year":"2002","unstructured":"Schreiber V, Am\u00e9 JC, Doll\u00e9 P, Schultz I, Rinaldi B, Fraulob V, M\u00e9nissier-de Murcia J, de Murcia G (2002) Poly (ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 277:23028\u201323036","journal-title":"J Biol Chem"},{"key":"768_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.dnarep.2007.01.009","volume":"6","author":"KH Almeida","year":"2007","unstructured":"Almeida KH, Sobol RW (2007) A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst) 6:695\u2013711","journal-title":"DNA Repair (Amst)"},{"key":"768_CR22","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/sj.onc.1209925","volume":"26","author":"CN Kundu","year":"2007","unstructured":"Kundu CN, Balusu R, Jaiswal AS, Gairola CG, Narayan S (2007) Cigarette smoke condensate-induced level of adenomatous polyposis coli blocks long-patch base excision repair in breast epithelial cells. Oncogene 26:1428\u20131438","journal-title":"Oncogene"},{"issue":"12","key":"768_CR23","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1021\/np070332i","volume":"70","author":"M L\u00f3pez-L\u00e1zaro","year":"2007","unstructured":"L\u00f3pez-L\u00e1zaro M, Willmore E, Jobson A, Gilroy KL, Curtis H, Padget K, Austin CA (2007) Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells. J Nat Prod 70(12):1884\u20131888","journal-title":"J Nat Prod"},{"key":"768_CR24","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1158\/1078-0432.CCR-06-3039","volume":"13","author":"CK Donawho","year":"2007","unstructured":"Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC (2007) ABT-888, an orally active poly (ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models. Clin Cancer Res 13:2728\u20132737","journal-title":"Clin Cancer Res"},{"key":"768_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrclinonc.2010.166","volume":"7","author":"SA Narod","year":"2010","unstructured":"Narod SA (2010) BRCA mutations in the management of breast cancer. Nat Rev Clin Oncol 7:702\u2013707","journal-title":"Nat Rev Clin Oncol"},{"key":"768_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1758834016687254","volume":"9","author":"T Evans","year":"2017","unstructured":"Evans T, Matulonis U (2017) PARP inhibitors in ovarian cancer: evidence, experience and clinical potential. Ther Adv Med Oncol 9:253\u2013267","journal-title":"Ther Adv Med Oncol"},{"key":"768_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.dnarep.2016.05.034","volume":"45","author":"S Siddharth","year":"2016","unstructured":"Siddharth S, Nayak D, Nayak A, Das S, Kundu CN (2016) ABT-888 and Quinacrine induced apoptosis in metastatic breast cancer stem cells by inhibiting base excision repair via adenomatous polyposis coli. DNA Repair (Amst) 45:44\u201355","journal-title":"DNA Repair (Amst)"},{"key":"768_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biocel.2015.07.009","volume":"66","author":"P Mohapatra","year":"2015","unstructured":"Mohapatra P, Satapathy SR, Siddharth S, Das D, Nayak A, Kundu CN (2015) Resveratrol and curcumin synergistically induce apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21Waf1\/Cip1mediated inhibition of Hh-Gli signaling. Int J Biochem Cell Biol 66:75\u201384","journal-title":"Int J Biochem Cell Biol"},{"key":"768_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/carcin\/bgs351","volume":"34","author":"R Preet","year":"2013","unstructured":"Preet R, Mohapatra P, Das D, Satapathy SR, Choudhuri T, Wyatt MD, Kundu CN (2013) Lycopene synergistically enhances Quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC. Carcinogenesis 34:277\u2013286","journal-title":"Carcinogenesis"},{"key":"768_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.taap.2013.09.028","volume":"274","author":"P Mohapatra","year":"2014","unstructured":"Mohapatra P, Preet R, Das D, Satapathy SR, Siddharth S, Choudhuri T, Wyatt MD, Kundu CN (2014) The contribution of heavy metals in cigarette smoke condensate to malignant transformation of breast epithelial cells and in vivo initiation of neoplasia through induction of a PI3K-AKT-NF\u03baB cascade. Toxicol Appl Pharmacol 274:168\u2013179","journal-title":"Toxicol Appl Pharmacol"},{"key":"768_CR31","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s10495-017-1400-4","volume":"22","author":"S Das","year":"2017","unstructured":"Das S, Tripathi N, Siddharth S, Nayak A, Nayak D, Sethy C, Bharatam PV, Kundu CN (2017) Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis. Apoptosis 22:1205\u20131224","journal-title":"Apoptosis"},{"key":"768_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrm831","volume":"3","author":"JC Wang","year":"2002","unstructured":"Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3:430","journal-title":"Nat Rev Mol Cell Biol"},{"key":"768_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/em.10072","volume":"39","author":"L Wang","year":"2002","unstructured":"Wang L, Eastmond DA (2002) Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187. Environ Mol Mutagen 39:348\u2013356","journal-title":"Environ Mol Mutagen"},{"key":"768_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/14756360310001613085","volume":"18","author":"C Mart\u00edn-Cordero","year":"2003","unstructured":"Mart\u00edn-Cordero C, L\u00f3pez-L\u00e1zaro M, G\u00e1lvez M, Ayuso MJ (2003) Curcumin as a DNA topoisomerase II poison. J Enzyme Inhibition Med Chem 18:505\u2013509","journal-title":"J Enzyme Inhibition Med Chem"},{"key":"768_CR35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrc2607","volume":"9","author":"JL Nitiss","year":"2009","unstructured":"Nitiss JL (2009) Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 9:338","journal-title":"Nat Rev Cancer"},{"key":"768_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.dnarep.2018.11.004","volume":"73","author":"R Prasad","year":"2019","unstructured":"Prasad R, Horton JK, Dai DP, Wilson SH (2019) Repair pathway for PARP-1 DNA-protein crosslinks. DNA Repair 73:71\u201377","journal-title":"DNA Repair"},{"key":"768_CR37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.4155\/ppa.13.53","volume":"2","author":"M Wielgos","year":"2013","unstructured":"Wielgos M, Yang ES (2013) Discussion of PARP inhibitors in cancer therapy. Pharm Pat Anal 2:755\u2013766","journal-title":"Pharm Pat Anal"},{"issue":"1-2","key":"768_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0027-5107(02)00028-3","volume":"503","author":"RD Snyder","year":"2002","unstructured":"Snyder RD, Arnone MR (2002) Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutat Res 503(1-2):21\u201335","journal-title":"Mutat Res"},{"key":"768_CR39","doi-asserted-by":"publisher","first-page":"12876","DOI":"10.1038\/s41598-017-13232-3","volume":"7","author":"CB Prasad","year":"2017","unstructured":"Prasad CB, Prasad SB, Yadav SS, Pandey LK, Singh S, Pradhan S, Narayan G (2017) Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property. Sci Rep 7:12876","journal-title":"Sci Rep"},{"key":"768_CR40","doi-asserted-by":"publisher","first-page":"18308","DOI":"10.1073\/pnas.0606526103","volume":"103","author":"SA Andrabi","year":"2006","unstructured":"Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, Sasaki M, Klaus JA, Otsuka T, Zhang Z, Koehler RC, Hurn PD (2006) Poly (ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci 103:18308\u201318313","journal-title":"Proc Natl Acad Sci"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-019-00768-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T20:01:56Z","timestamp":1606161716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-019-00768-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s12253-019-00768-0","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"13 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}